13 December, 2013
CCA is delighted to welcome an historic $500,000 matched funding agreement granted by the Federal Government that will change the lives of thousands of Australians living with incurable inflammatory bowel disease.
The matched funding agreement calls for the corporate and philanthropic sector to partner with CCA and the Federal Government to implement the recommendations of the groundbreaking PwC report ‘Improving Inflammatory Bowel Disease Care Across Australia’. The report called for a national audit to improve available resources and patient care.
CCA Chief Executive Officer, Francesca Manglaviti said:
“The pledge from Health Minister, The Hon Peter Dutton, acknowledges the work of CCA and better understanding of the importance of early diagnosis and effective treatment for people living with Crohn’s disease and ulcerative colitis.
Ms Manglaviti also acknowledged the support of the Federal Crohn’s & Colitis Friendship Group.
“We are grateful to the Crohn’s and Colitis Parliamentary Group, and key members, The Hon Bernie Ripoll MP, Federal Member for Oxley and The Hon Josh Frydenberg MP, Federal Member for Kooyong. Their support for this initiative ensures the much needed national audit of IBD care in over 100 hospitals will take place.
Mr Ripoll urged corporate Australia and community supporters to get behind the drive to fund the project. “It will make an enormous difference to the quality of life for thousands of young Australians suffering from this debilitating disease.”
Mr Frydenberg said: “This is wonderful news for the sufferers of Crohn’s and Colitis and their families. Crohn’s and Colitis are debilitating chronic illnesses and government, working with the private sector, has an important role to play in providing better treatment and support to the over 75,000 Australians living with an inflammatory bowel disease”
With 1 in 250 people aged 5-49 affected by this chronic and largely hidden disease, Australia has one of the highest rates of IBD in the world. By 2022 there will be an estimated 100,000 Australians with IBD, according to the PwC report.
“The cost of this disease, in both human and monetary terms, is staggering,” Ms Manglaviti said. “$2.7 billion of financial and economic costs each year are associated with the management of IBD. Annual productivity costs attributed to IBD are estimated at over $380 million. In addition, each year we as a community incur $100 million in hospital costs for IBD.”
“Early diagnosis and consistent quality care can significantly reduce both the need for and cost of hospitalisation and preventable surgery. The audit will help identify where resources are needed to ensure patients receive quality care.
“We now need to raise the remaining $500,000 required to conduct the audit. It will make a huge difference to the quality of life for thousands of young Australians living with IBD.”